Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$8.16 - $15.1 $2.16 Million - $3.99 Million
-264,111 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$11.2 - $16.97 $401,956 - $609,036
-35,889 Reduced 11.96%
264,111 $3.89 Million
Q4 2021

Feb 07, 2022

BUY
$12.36 - $18.28 $2.16 Million - $3.2 Million
175,000 Added 140.0%
300,000 $3.97 Million
Q3 2021

Nov 09, 2021

BUY
$17.11 - $24.49 $2.14 Million - $3.06 Million
125,000 New
125,000 $2.18 Million
Q4 2018

Feb 12, 2019

SELL
$16.21 - $24.06 $1.3 Million - $1.92 Million
-80,000 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$8.0 - $22.11 $640,000 - $1.77 Million
80,000 New
80,000 $1.77 Million

Others Institutions Holding KALV

About KalVista Pharmaceuticals, Inc.


  • Ticker KALV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,602,000
  • Market Cap $217M
  • Description
  • KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...
More about KALV
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.